Elmet Group Q2 FY26 earnings call ELMT

Elmet Group highlighted its unique position as the sole U.S.-based provider of certain precision engineered refractory metal components and high-power microwave systems. The company benefits from macro tailwinds such as defense fortification, U.S. reshoring, and a focus on material independence, which are driving backlog and future growth. Its vertically integrated operations and difficult-to-replicate asset base create high barriers to entry, supporting a strong long-term outlook.

The significant rise in tungsten and molybdenum prices, exacerbated by export controls, has been a major factor impacting results. Elmet's strategy of sourcing over 95% of these materials from outside China for over a decade, combined with strategic sourcing agreements, has largely shielded it from supply chain disruption^🌐s and allowed it to capture benefits from price increases. This dynamic drove a portion of the Q2 backlog increase and contributed to gross margin expansion.

To support accelerating demand, Elmet is investing in growth, including significant increases in staffing and third-party support for its Critical Materials Components (CMC) factories, which are already yielding favorable productivity impacts. The company secured $4.3 million in strategic funding to develop and advance domestic manufacturing capabilities for molybdenum-based products used in critical defense programs, aiming to expand capacity and deploy advanced manufacturing technologies.

The Aerospace, Defense, and Government (ADG) end market backlog was up 100.5% year-over-year, driven by new and growing programs such as CERN, Strategic Missile Systems, PrSM, Standard Missile, and Patriot. Management noted that while large multi-year awards to primes haven't fully flowed down yet, they anticipate continued funding opportunities from the ongoing budget and appropriation cycle, expecting ADG to drive long-term growth at higher margins.

The decline in backlog outside of ADG was primarily attributed to the inconsistent order patterns of a large medical customer, which creates volatility in the 'other' segment. While actual demand from this customer is up year-over-year, their ordering behavior impacts quarterly backlog. Other end markets like industrial and semiconductor are showing traction, with industrial seeing an uptick in both CMC and EMP divisions, and energy demand awaiting fusion and vision development cycles.

The EMP division experienced operational challenges in Q2, particularly in the factory dealing with higher-margin ADG and semiconductor products. This impacted EMP's EBITDA margins. Management is diligently working to correct these issues in the second half of the year, expecting some improvement but acknowledging it will take time to fully resolve.